Pfizer Inc. (PFE): Price and Financial Metrics

PFE POWR Grades

• Value is the dimension where PFE ranks best; there it ranks ahead of 98.3% of US stocks.
• The strongest trend for PFE is in Growth, which has been heading down over the past 179 days.
• PFE's current lowest rank is in the Growth metric (where it is better than 2.47% of US stocks).

PFE Stock Summary

• PFE has a higher market value than 99.35% of US stocks; more precisely, its current market capitalization is $218,078,210,183.
• PFE's went public 37.42 years ago, making it older than 93.61% of listed US stocks we're tracking.
• PFE's current price/earnings ratio is 7.51, which is higher than just 23.16% of US stocks with positive earnings.
• Stocks with similar financial metrics, market capitalization, and price volatility to PFIZER INC are NVS, CSCO, ABBV, NFLX, and SAP.
• Visit PFE's SEC page to see the company's official filings. To visit the company's web site, go to www.pfizer.com.

PFE Valuation Summary

• In comparison to the median Healthcare stock, PFE's price/sales ratio is 9.09% higher, now standing at 2.4.
• PFE's price/earnings ratio has moved down 13.2 over the prior 243 months.

Below are key valuation metrics over time for PFE.

PFE Growth Metrics

Its 4 year net cashflow from operations growth rate is now at -11.47%.
• The 3 year revenue growth rate now stands at 71.5%.
• Its 5 year cash and equivalents growth rate is now at -46.98%.

Over the past 49 months, PFE's revenue has gone up $46,303,000,000.

The table below shows PFE's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	99,676	26,599	29,771
2022-06-30	101,132	31,454	29,309
2022-03-31	92,367	34,583	24,966
2021-12-31	81,288	32,580	21,979
2021-09-30	63,600	32,291	19,180
2021-06-30	51,637	23,552	13,228

PFE's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• PFE has a Quality Grade of B, ranking ahead of 88% of graded US stocks.
• PFE's asset turnover comes in at 0.312 -- ranking 146th of 682 Pharmaceutical Products stocks.
• XBIT, NERV, and BLUE are the stocks whose asset turnover ratios are most correlated with PFE.

The table below shows PFE's key quality metrics over time.